FREMONT, Calif., Nov. 10, 2015 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN) announced today that Vikram Lamba, Chief Executive Officer, will provide a company overview at the Stifel 2015 Healthcare Conference on November 17, 2015. The presentation will take place from 2:15 to 2:55 p.m. ET at the New York Palace Hotel in New York, New York.
A copy of the presentation can be accessed through the Zosano website at http://www.zosanopharma.com. Under the "Investors" tab, select the link to "Events & Presentations."
About Zosano Pharma
Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company that has developed a proprietary transdermal microneedle patch system to deliver drug formulations through the skin for the treatment of a variety of indications. Zosano Pharma's microneedle patch system offers rapid onset, consistent drug delivery, improved ease of use and room-temperature stability, benefits that the company believes often are unavailable using oral formulations or injections. Zosano Pharma's microneedle patch system has the potential to deliver numerous medications for a wide variety of indications in commercially attractive markets. It has been tested in more than 400 patients with over 30,000 patches successfully applied to humans in Phase 1 and Phase 2 clinical studies. Learn more at www.zosanopharma.com.
Zosano Contact: Vikram Lamba Chief Executive Officer 510-745-1200 Investor Contact: Patti Bank Westwicke Partners 415-513-1284 firstname.lastname@example.org Media Contact: Jamie Lacey-Moreira PressComm PR, LLC 410-299-3310 email@example.com
Source:Zosano Pharma, Inc